PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1CD38 cells and anti-PD-1 resistance

Journal: Nature Immunology

Published: 2019-07-29

DOI: 10.1038/s41590-019-0441-y

Affiliations: 16

Authors: 28

Go to article
Institutions Share
Georgia Cancer Center, Augusta University, United States of America (USA) 0.26
Georgetown Lombardi Comprehensive Cancer Center, United States of America (USA) 0.14
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA) 0.11
Department of Medicine, MGH, United States of America (USA) 0.08
Cancer Center, MGH, United States of America (USA) 0.08
Broad Institute of MIT and Harvard, United States of America (USA) 0.08
Department of Surgical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.04
Department of Surgery, MGH, United States of America (USA) 0.04
AstraZeneca Gaithersburg, MD, United States of America (USA) 0.04
Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, United States of America (USA) 0.04
Weill Cornell Graduate School of Medical Sciences (WCGS, Cornell-MSKCC), United States of America (USA) 0.04
Division of Therapeutics Discovery, MD Anderson Cancer Center, United States of America (USA) 0.02
Five Prime Therapeutics, Inc., United States of America (USA) 0.02
Incyte Corporation, United States of America (USA) 0.02
A2 Biotherapeutics, Inc., United States of America (USA) 0.01
Department of Pathology, MGH, United States of America (USA) 0.01

Return